Advertisement

International Journal of Clinical Pharmacy

, Volume 38, Issue 5, pp 1149–1156 | Cite as

Impact of medication reconciliation at discharge on continuity of patient care in France

  • Mélanie Van HollebekeEmail author
  • Sarah Talavera-Pons
  • Aurélien Mulliez
  • Valérie Sautou
  • Gilles Bommelaer
  • Armand Abergel
  • Anne Boyer
Research Article

Abstract

Background Care transitions from hospital to community have been identified as risk points for the continuity of patient care. Without upstream information, the community pharmacist (CP) cannot ensure error-free drug dispensing. A hospital-to-community records transmission process would enable CPs to guarantee that all prescription drugs are ready to pick up at hospital discharge, and to improve their responses to patient health inquiries. Objective To evaluate the impact of a hospital-to-CP medication records scheme on post-discharge continuity of patient treatment. Setting A University Hospital Digestive Surgery Department. Method Prospective, single-center, randomized pilot study. Eligible adult Digestive Surgery department patients discharged home over a period of 4 months were included. The medication reconciliation procedure was the same in both arms of the study. For patients included in the intervention group, CPs were sent the discharge prescription, patient medication list, and clinical and biological data required for drug dispensing. At 7 ± 2 days post-discharge, the CPs were surveyed by questionnaire. Seamlessness of drug continuity, use of the discharge medication form, and CP satisfaction with the scheme were assessed. Main outcome measures Prevalence of medication shortages, i.e. CPs unable to supply the appropriate drugs at discharge, and CP satisfaction levels, analyzed using Chi squared test. Results 124 patients were included. Of 124 CPs surveyed, 104 returned a completed questionnaire. Analysis found medication shortage in 10 control-group patients and one intervention-group patient (p < 0.005), non-availability of the full prescription in 24 % of control-group patients and 6 % of intervention-group patients (p < 0.013). In terms of CP satisfaction, 96 % of the intervention-group CPs stated that they were satisfied with the new hospital-to-community liaison initiative, while just 24 % of control-group CPs were satisfied with the current level of hospital-to-community liaison. Mean hospital pharmacist time input required for this initiative was an estimated 21 min for the control group versus 35 min for the intervention group. Conclusion The results provide a strong rationale for embedding the process longer-term and extending it out to other healthcare services. A pre-project study is needed to define which service departments and patients groups should be given priority for this process initiative.

Keywords

Community pharmacy Continuity of treatment France Hospital discharge Seamless care 

Notes

Funding

None.

Conflicts of interest

None.

Supplementary material

11096_2016_344_MOESM1_ESM.docx (17 kb)
Supplementary material 1 (DOCX 17 kb)
11096_2016_344_MOESM2_ESM.docx (18 kb)
Supplementary material 2 (DOCX 17 kb)

References

  1. 1.
    Muecke S, Kalucy E, McIntyre. Continuity and safety in care transitions: communication at the hospital/community care interface. Australian RESEARCH ROUNDup; 2010. Last cited 01-2016. http://www.phcris.org.au/phplib/filedownload.php?file=/elib/lib/downloaded_files/publications/pdfs/news_8330.pdf.
  2. 2.
    Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138:161–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Makeham MA, Kidd MR, Saltman DC, Mira M, Bridges-Webb C, Cooper C, et al. The threats to Australian patient safety (TAPS) study: incidence of reported errors in general practice. MJA. 2006;185(2):95–8.PubMedGoogle Scholar
  4. 4.
    Paulino EI, Bouvy ML, Gastelurrutia MA, Guerreiro M, Buurma H. Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci. 2004;26(6):353–60.PubMedGoogle Scholar
  5. 5.
    Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005;20:317–23.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Climente-Martí M, García-Mañón ER, Artero-Mora A, Jiménez-Torres NV. Potential risk of medication discrepancies and reconciliation errors at admission and discharge from an inpatient medical service. Ann Pharmacother. 2010;44(11):1747–54.CrossRefPubMedGoogle Scholar
  7. 7.
    Tsilmingras D, Bates DW. Addressing postdischarge adverse events: a neglected area. Jt Comm J Qual Patient Saf. 2008;34(2):85–97.Google Scholar
  8. 8.
    Eggink RN, Lenderink AW, Widdershoven JW, van den Bemt PM. The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure. Pharm World Sci. 2010;32(6):759–66.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Directorate General of Health. Instruction No. DGOS/PF2/2015/65 of 9 March 2015 concerning the implementation of a national survey on the deployment of the drug conciliation in health facilities; 2015. Last cited 06-2015. http://www.snphpu.org/files/20150409_InstructionDGOSEnquetedeploiementconciliationmedicamenteuseEtsdesante.pdf.
  10. 10.
    Karapinar-Carkit F, Borgsteede SD, Zoer J, Smit HJ, Egberts AC, van den Bemt PM. Effect of medication reconciliation with and without patient counselling on the number of pharmaceutical interventions among patients discharged from the hospital. Ann Pharmacother. 2009;43(6):1001–10.CrossRefPubMedGoogle Scholar
  11. 11.
    Grimmsmann T, Schwabe U, Himmel W. The influence of hospitalisation on drug prescription in primary care: a large-scale follow-up study. Eur J Clin Pharmacol. 2007;63(8):783–90.CrossRefPubMedGoogle Scholar
  12. 12.
    Himmel W, Kochen MM, Sorns U, Hummers-Pradier E. Drug changes at the interface between primary and secondary care. Int J Clin Pharmacol Ther. 2004;42(2):103–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Himmel W, Tabache M, Kochen MM. What happens to long-term medication when general practice patients are referred to hospital? Eur J Clin Pharmacol. 1996;50(4):253–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Cochrane RA, Mandal AR, Ledger-Scott M, Walker R. Changes in drug treatment after discharge from hospital in geriatric patients. BMJ. 1992;305(6855):694–6.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Mansur N, Weiss A, Beloosesky Y. Relationship of in-hospital medication modifications of elderly patients to postdischarge medications, adherence, and mortality. Ann Pharmacother. 2008;42(6):783–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Baumbusch J, Semeniuk P, McDonald H, Khan KB, Reimer Kirkham S, Tan E, et al. Easing the transition between hospital and home: translating knowledge into action. Can Nurse. 2007;103(8):24–9.PubMedGoogle Scholar
  17. 17.
    Kripalani S, Jackson AT, Schnipper JL, Coleman EA. Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists. J Hosp Med. 2007;2(5):314–23.CrossRefPubMedGoogle Scholar
  18. 18.
    Micheli P, Kossovsky MP, Gerstel E, Louis-Simonet M, Sigaud P, Perneger TV, et al. Patients’ knowledge of drug treatments after hospitalisation: the key role of information. Swiss Med Wkly. 2007;137(43–44):614–20.PubMedGoogle Scholar
  19. 19.
    Munday A, Kelly B, Forrester JW, Timoney A, McGovern E. Do general practitioners and community pharmacists want information on the reasons for drug therapy changes implemented by secondary care? Br J Gen Pract. 1997;47(422):563–6.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Roughead EE, Kalisch LM, Ramsay EN, Ryan P, Gilbert AL. Continuity of care: when do patients visit community healthcare providers after leaving hospital? Intern Med J. 2011;41(9):662–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Nazar H, Nazar Z, Portlock J, Todd A, Slight SP. A systematic review of the role of community pharmacies in improving the transition from secondary to primary care. Br J Clin Pharmacol. 2015;80(5):936–48.CrossRefPubMedGoogle Scholar
  22. 22.
    Urban R, Paloumpi E, Rana N, Morgan J. Communicating medication changes to community pharmacy post-discharge: the good, the bad, and the improvements. Int J Clin Pharm. 2013;35(5):813–20.CrossRefPubMedGoogle Scholar
  23. 23.
    Cavrenne P, Spinewine A. Continuity in patient care upon hospital discharge: evaluation of a clinical pharmacy discharge form for community pharmacists. J Pharm Belg. 2008;63(3):69–72.PubMedGoogle Scholar
  24. 24.
    Mallet L. Case study 3: continuity in geriatric patient care. Can Pharm Union. 2003;31:1–4.Google Scholar
  25. 25.
    Morrisson P, Abu-Arafeh I. Optimum prescribing of discharge medecines: roles of hospital and community pharmacists. Pharm J. 2004;272:224–7.Google Scholar
  26. 26.
    Hugtenburg JG, Borgsteede SD, Beckeringh J. Medication review and patient counselling at discharge from the hospital by community pharmacists. J Pharm World Sci. 2009;31(6):630–7.CrossRefGoogle Scholar
  27. 27.
    Bolas H, Brookes K, Scott M, McElnay J. Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland. J Pharm World Sci. 2004;26(2):114–20.CrossRefGoogle Scholar
  28. 28.
    Burra P, Germani G, Gnoato F, Lazzaro S, Russo FP, Cillo U, et al. Adherence in liver transplant recipients. Liver Transpl. 2011;17(7):760–70.CrossRefPubMedGoogle Scholar
  29. 29.
    Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant. 2009;9:2597–606.CrossRefPubMedGoogle Scholar
  30. 30.
    Guillemotonia MJ, Gosselin B, Brechet MP, Fantin D, Hoskovec C, Delemme C. Management of oral chemotherapy in the city hospital network—hospital experience of Mont de Marsan. In: Proceedings of the 7th congress of the French society of oncology pharmacy; 2011. Last cited 06-2015. http://sfpo.com/squelettes/pdf/LivreCongresSFPO2011.pdf.
  31. 31.
    Preece D, Holme K, Frontini R, Tromp D, Price R. Admission into primary care: are we doing enough? Eur J Hosp Pharm. 2014;21:79–83.CrossRefGoogle Scholar
  32. 32.
    Mant A, Rotem WC, Kehoe L, Kaye KI. Compliance with guidelines for continuity of care in therapeutics from hospital to community. Med J Aust. 2001;174(6):277–80.PubMedGoogle Scholar
  33. 33.
    NICE. Transition between inpatient hospital settings and community or care home settings for adults with social care needs. NICE; 2015. Last cited 01-2016. ISBN:978-1-4731-1545-3, http://www.nice.org.uk/guidance/ng27.
  34. 34.
    Pharmacy Hand off Communication Resources. Pharmacy Society of Wisconsin; 2015. Last cited 01-2016. http://www.pswi.org/Resources/PSW-Transitions-of-Care-Toolkit/Pharmacy-Hand-off-Communication.
  35. 35.
    Gray A. Refer-to-pharmacy: pharmacy for the next generation now! A short communication for pharmacy. Pharmacy. 2015;3:364–71.CrossRefGoogle Scholar
  36. 36.
    Robinson S. Hospital e-referral initiative boosts post-discharge MURs in community pharmacies. Pharm J. 2015;295:7872–3.Google Scholar
  37. 37.
    Adenot I (President of the National Council of the Order of Pharmacists). “Le Dossier Pharmaceutique”—progress report 2012. National Council of the Order of Pharmacists; 2013, updated Apr 2015. Last cited 06-2015. http://www.ordre.pharmacien.fr/Le-Dossier-Pharmaceutique/Le-DP-raconte-par-Isabelle-Adenot.
  38. 38.
    Kristeller J. Transition of care: pharmacist help needed. Hosp Pharm. 2014;49(3):215–6.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing 2016

Authors and Affiliations

  • Mélanie Van Hollebeke
    • 1
    Email author
  • Sarah Talavera-Pons
    • 1
  • Aurélien Mulliez
    • 3
  • Valérie Sautou
    • 1
  • Gilles Bommelaer
    • 2
  • Armand Abergel
    • 2
  • Anne Boyer
    • 1
  1. 1.Pharmacy DepartmentUniversity Hospital of Clermont-FerrandClermont-FerrandFrance
  2. 2.Gastro Enterology DepartmentUniversity Hospital of Clermont-FerrandClermont-FerrandFrance
  3. 3.Clinical Research and Innovation OfficeUniversity Hospital of Clermont-FerrandClermont-FerrandFrance

Personalised recommendations